VerImmune

Seed
verimmune.com Biotech & Healthcare
Total Funding $3.1M
Latest Round $3.1M Seed
Last Announced Sep 20, 2023
Investors Undisclosed
Decision Makers 5 Verified

About VerImmune

VerImmune is developing Anti-Tumor Immune Redirection (AIR): a breakthrough therapy that redirects immune memory against pathogens or childhood vaccines to target cancer.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website verimmune.com
Domain Registered Date Aug 21, 2019

Social & Network Presence

X / Twitter Profile @VerImmune_ (17 followers) Created on Jan 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $3,120,000 · Seed

    startupintros.com

  2. Milestone

    X account created (@VerImmune_)

    17 followers

  3. Milestone

    Website domain registered

    verimmune.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for VerImmune.

Funding History

1 Round
Seed · Sep 20, 2023

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts